Rare diseases
Investigational molecules
Locations
4 F, No 3-2 Park St., Nangang Dist., 115603
Research activity is centered on acute ischemic stroke, with attention to clinical outcomes relevant to cerebrovascular disease and brain ischemia.
Clinical interest extends to treatment settings that address acute neurological events and the preservation of brain function after ischemic injury.
Lumosa Therapeutics Co. Ltd. runs clinical trials in conditions such as Ischaemic stroke, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
